eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
4/2022
vol. 9
 
Share:
Share:
abstract:
Review paper

Current allergen immunotherapy market situation – September 2022

Adam Górka
1
,
Rafał Pawliczak
1

  1. Zakład Immunopatologii, Wydział Lekarski, Uniwersytet Medyczny, Łódź, Polska
Alergologia Polska – Polish Journal of Allergology 2022; 9, 4: 246–249
Online publish date: 2022/12/09
View full text Get citation
 
PlumX metrics:
Immunotherapy pharma market has been still increasing in Poland in the last 20 years. The number of practicing allergist increased by 10 fold, enhancing access to allergy healthcare. Internal and external factors influenced the patients’ access to the specific immunotherapy. During last two years a vast decrease in the number of patient undergoing allergen specific immunotherapy was noted. This may affect public health in the near feature.
keywords:

pharma market, allergen immunotherapy



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.